Characteristics of Undertreatment in COPD in the General Population

被引:33
作者
Ingebrigtsen, Truls S. [1 ,4 ]
Marott, Jacob L. [4 ]
Vestbo, Jorgen [1 ,10 ]
Hallas, Jesper [2 ,3 ]
Nordestgaard, Borge G. [5 ,6 ]
Dahl, Morten [7 ]
Lange, Peter [4 ,8 ,9 ]
机构
[1] Odense Univ Hosp, Dept Resp Med, Odense, Denmark
[2] Odense Univ Hosp, Dept Clin Pharmacol, Odense, Denmark
[3] Univ Southern Denmark, Inst Clin, Odense, Denmark
[4] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark
[5] Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark
[6] Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark
[7] Rigshosp, Copenhagen Univ Hosp, Hvidovre Hosp, Dept Clin Biochem, Copenhagen, Denmark
[8] Copenhagen Univ Hosp, Hvidovre Hosp, Resp Sect, Copenhagen, Denmark
[9] Univ Copenhagen, Inst Publ Hlth, Dept Social Med, Copenhagen, Denmark
[10] Univ Hosp South Manchester NHS Fdn Trust, Resp Res Grp, Manchester Acad Hlth Sci Ctr, Manchester, England
关键词
OBSTRUCTIVE PULMONARY-DISEASE; MEDICATION ADHERENCE; EXACERBATIONS; TIOTROPIUM; BURDEN; PERSISTENCE; PREVENTION; PREVALENCE; SALMETEROL; CARE;
D O I
10.1378/chest.13-0453
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: We wished to characterize undertreatment in COPD. Methods: Among 5,812 individuals with COPD defined by FEV1/FVC, 0.7 participating in the Copenhagen General Population Study, we identified 920 individuals with FEV1, 60% predicted. Prescriptions were identified in an all-inclusive nationwide registry. For each individual, we examined treatment with medication in the year before the day of the baseline examination, as well as treatment in the first year after the examination. Multivariable logistic regression analyses were applied in individuals with FEV1, 60% predicted to identify predictors of treatment in the first year after baseline. Results: Only 30% of individuals with COPD and FEV1, 60% predicted were treated with medication in the year before the examination, whereas 42.2% were treated with medication in the first year after. Reporting six to 10 previous respiratory infections during the preceding 10 years that required consulting a doctor and/or staying home from work was the strongest predictor of treatment with medication (OR, 7.9; 95% CI, 3.5-19.8; P<.001). Breathlessness, low FEV1, previous admissions with a discharge diagnosis of COPD, and former smoking were also predictors of treatment with medication, whereas comorbidity predicted lack of treatment. In subgroup analysis, among individuals with FEV1 <50% predicted, visits to the general practitioner and age were additional predictors of treatment, whereas male sex and being a widow/widower predicted lack of treatment. Conclusions: In this study, we observed important characteristics of a major undertreatment in individuals with COPD in the general population. Previous reported respiratory infections were the strongest predictors of treatment with medications, which indicates that most COPD treatment is initiated because of acute exacerbations.
引用
收藏
页码:1811 / 1818
页数:8
相关论文
共 30 条
[21]   Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease - GOLD executive summary [J].
Rabe, Klaus F. ;
Hurd, Suzanne ;
Anzueto, Antonio ;
Barnes, Peter J. ;
Buist, Sonia A. ;
Calverley, Peter ;
Fukuchi, Yoshinosuke ;
Jenkins, Christine ;
Rodriguez-Roisin, Roberto ;
van Weel, Chris ;
Zielinski, Jan .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (06) :532-555
[22]  
Restrepo Ruben D, 2008, Int J Chron Obstruct Pulmon Dis, V3, P371
[23]   The prevalence of undiagnosed chronic obstructive pulmonary disease in a primary care population with respiratory tract infections - a case finding study [J].
Sandelowsky, Hanna ;
Stallberg, Bjorn ;
Nager, Anna ;
Hasselstrom, Jan .
BMC FAMILY PRACTICE, 2011, 12
[24]   Association of Chronic Obstructive Pulmonary Disease Maintenance Medication Adherence With All-Cause Hospitalization and Spending in a Medicare Population [J].
Simoni-Wastila, Linda ;
Wei, Yu-Jung ;
Qian, Jingjing ;
Zuckerman, Ilene H. ;
Stuart, Bruce ;
Shaffer, Thomas ;
Dalal, Anand A. ;
Bryant-Comstock, Lynda .
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2012, 10 (03) :201-210
[25]   A 4-year trial of tiotropium in chronic obstructive pulmonary disease [J].
Tashkin, Donald P. ;
Celli, Bartolome ;
Senn, Stephen ;
Burkhart, Deborah ;
Kesten, Steven ;
Menjoge, Shailendra ;
Decramer, Marc .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15) :1543-1554
[26]   Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease [J].
Thomsen, Mette ;
Ingebrigtsen, Truls Sylvan ;
Marott, Jacob Louis ;
Dahl, Morten ;
Lange, Peter ;
Vestbo, Jorgen ;
Nordestgaard, Borge G. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (22) :2353-2361
[27]  
Touchette DR, 2008, J MANAGE CARE PHARM, V14, pS2
[28]  
Vestbo J, 2006, EUR RESPIR MONOGR, P463, DOI 10.1183/1025448x.00038028
[29]   Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD [J].
Vogelmeier, Claus ;
Hederer, Bettina ;
Glaab, Thomas ;
Schmidt, Hendrik ;
Rutten-van Molken, Maureen P. M. H. ;
Beeh, Kai M. ;
Rabe, Klaus F. ;
Fabbri, Leonardo M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (12) :1093-1103
[30]   Predictors of Medication Nonadherence Among Patients With Diabetes in Medicare Part D Programs: A Retrospective Cohort Study [J].
Yang, Yi ;
Thumula, Vennela ;
Pace, Patrick F. ;
Banahan, Benjamin F., III ;
Wilkin, Noel E. ;
Lobb, William B. .
CLINICAL THERAPEUTICS, 2009, 31 (10) :2178-2188